Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Learning from errors: response to gefitinib in kidney urothelial carcinoma with EGFR mutations.

The oncologist - 1 Apr 2014

Fiorentino Michelangelo, Giunchi Francesca, Altimari Annalisa, Di Tullio Piergiorgio, Gruppioni Elisa, Martorana Giuseppe, Pinto Carmine

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carboplatin
Share to Deoxycytidine
Share to Gefitinib
Share to Gemcitabine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney

Share to Kidney Neoplasms

Share to Quinazolines

Share to Urothelium

Source

Open in PubMed Open full text

Identifiers

PMID: 24652385
DOI: 10.1634/theoncologist.2013-0346
PMCID: PMC3983821

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Learning from errors: response to gefitinib in kidney urothelial carcinoma with EGFR mutations.PMID 24652385Read ↗

High T790M detection rate in TKI-naive NSCLC with EGFR sensitive mutation: truth or artifact?Semantic proximity Read ↗

EGFR mutations in non-small cell lung carcinomas may predict response to gefitinib: extension of an emerging paradigm.Semantic proximity Read ↗

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung CancerSemantic proximity Read ↗

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow.Semantic proximity Read ↗

A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testingSemantic proximity Read ↗

Predictive tests for EGFR inhibitors.Semantic proximity Read ↗

Integrated machine learning survival framework for consensus modeling in a large multicenter cohort of NSCLC resistant to aumolertinibSemantic proximity Read ↗

Learning from cancer mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.